DK0539525T3 - Vitalethein og anvendelse deraf i cellekultur og terapi - Google Patents

Vitalethein og anvendelse deraf i cellekultur og terapi

Info

Publication number
DK0539525T3
DK0539525T3 DK91915854T DK91915854T DK0539525T3 DK 0539525 T3 DK0539525 T3 DK 0539525T3 DK 91915854 T DK91915854 T DK 91915854T DK 91915854 T DK91915854 T DK 91915854T DK 0539525 T3 DK0539525 T3 DK 0539525T3
Authority
DK
Denmark
Prior art keywords
vitalethein
therapy
cell culture
vitaletheine
cell
Prior art date
Application number
DK91915854T
Other languages
Danish (da)
English (en)
Inventor
Galen Daryl Knight
Terence Joseph Scallen
Original Assignee
Univ New Mexico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New Mexico filed Critical Univ New Mexico
Application granted granted Critical
Publication of DK0539525T3 publication Critical patent/DK0539525T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0025Culture media for plant cell or plant tissue culture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40Y being a hydrogen or a carbon atom
    • C07C323/41Y being a hydrogen or an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • C12N2500/33Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK91915854T 1990-07-06 1991-07-08 Vitalethein og anvendelse deraf i cellekultur og terapi DK0539525T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54910590A 1990-07-06 1990-07-06
US54944090A 1990-07-06 1990-07-06
US54943890A 1990-07-06 1990-07-06
PCT/US1991/004726 WO1992000955A1 (en) 1990-07-06 1991-07-08 Vitaletheine and use in cell culture and therapy

Publications (1)

Publication Number Publication Date
DK0539525T3 true DK0539525T3 (da) 2000-04-10

Family

ID=27415550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915854T DK0539525T3 (da) 1990-07-06 1991-07-08 Vitalethein og anvendelse deraf i cellekultur og terapi

Country Status (10)

Country Link
EP (1) EP0539525B1 (ja)
JP (1) JP3259960B2 (ja)
AT (1) ATE186048T1 (ja)
AU (1) AU655598B2 (ja)
DE (1) DE69131752T2 (ja)
DK (1) DK0539525T3 (ja)
ES (1) ES2139580T3 (ja)
GR (1) GR3031801T3 (ja)
HK (1) HK1014367A1 (ja)
WO (1) WO1992000955A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718140B2 (en) * 1995-10-17 2000-04-06 Dovetail Technologies, Inc. Low molecular weight cell, bone marrow and immune stimulants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495857B1 (fr) * 1980-08-27 1987-11-27 Petit Jean Filtre numerique recursif de surechantillonnage en arithmetique distribuee
US4552765A (en) * 1982-05-14 1985-11-12 Santen Pharmaceutical Co., Ltd. Aletheine derivatives
DE69113802T2 (de) * 1990-07-06 1996-05-15 Univ New Mexico Anwendung von beta-alethin in zellkultur und therapie.

Also Published As

Publication number Publication date
HK1014367A1 (en) 1999-09-24
GR3031801T3 (en) 2000-02-29
EP0539525A1 (en) 1993-05-05
WO1992000955A1 (en) 1992-01-23
EP0539525B1 (en) 1999-10-27
JPH06500106A (ja) 1994-01-06
ATE186048T1 (de) 1999-11-15
ES2139580T3 (es) 2000-02-16
AU8500891A (en) 1992-02-04
EP0539525A4 (ja) 1994-01-12
AU655598B2 (en) 1995-01-05
JP3259960B2 (ja) 2002-02-25
DE69131752T2 (de) 2000-06-29
DE69131752D1 (de) 1999-12-02

Similar Documents

Publication Publication Date Title
BR9910251A (pt) Estimulação hematopoiética
DK1242578T3 (da) Celledyrkningsmedium indeholdende vækstfaktorer og L-glutamin
ES2147203T3 (es) Procedimientos de inactivacion de bacterias en las preparaciones a base de sangre con la ayuda de 8-metoxipsoraleno.
MX9101913A (es) Derivados de quinazolinas para potenciar la actividad antitumoral
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
EA200400482A1 (ru) Кератиноциты, пригодные для применения в качестве биологически активной субстанции при лечении ран
DE69535081D1 (de) Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
FI920430A0 (fi) Benzyloxifenylderivator.
PT862452E (pt) Formulacao de estabilizacao para o ngf
EP0809437A4 (en) THIOLS USED TO PROMOTE THE GROWTH OF PARENT HEMATOPOIETIC CELLS
DE3850778D1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
DK0539525T3 (da) Vitalethein og anvendelse deraf i cellekultur og terapi
DK0538330T3 (da) Beta-Alethin-anvendelse til celledyrkning og terapi
DK0563256T3 (da) Anvendelse af værtscelle-phospholipider til inhibering af bakteriekolonisering
ATE125571T1 (de) Interleukin-1-inhibitor.
ES2154290T3 (es) Estimulacion de la diferenciacion celular por sindecano.
PT883406E (pt) Utilizacao da il-7 no tratamento das doencas auto-imunes em particular a diabetes mellitus insulinodependente
FR2835429B1 (fr) Utilisation d'acide ascorbique pour renforcer la cohesion de la jonction dermo-epidermique
PH23658A (en) Improved method of treating tumors with autologous lymphokine activated killer,interleukin-2 and an ornithine decarboxylase inhibitor
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
AU8478601A (en) Methods for culturing human lung mast cells and uses thereof
DK0542891T3 (da) Biologisk aktive forbindelser fra blågrønalger
DE60201935D1 (de) Verwendung von Biguanid und Pyrimidin-Derivaten zur Herstellung topischer Hautpflegezubereitungen
ATE69551T1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.